相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Protective efficacy of 6-week regimen for latent tuberculosis infection treatment in rural China: 5-year follow-up of a randomised controlled trial
Henan Xin et al.
EUROPEAN RESPIRATORY JOURNAL (2022)
Risk factors associated with unsuccessful tuberculosis treatment outcomes in Hunan Province, China
Beth Gilmour et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2022)
Recurrent pulmonary tuberculosis after treatment success: a population-based retrospective study in China
Qiao-ling Ruan et al.
CLINICAL MICROBIOLOGY AND INFECTION (2022)
Promoting the quality and transparency of health research in China
Yanfang Ma et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2022)
Recurrent TB: a systematic review and meta-analysis of the incidence rates and the proportions of relapses and reinfections
Victor Vega et al.
THORAX (2021)
Management of latent tuberculosis infection in China: Exploring solutions suitable for high-burden countries
Xiaojing Cui et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
Drug-Induced Liver Injury from Anti-Tuberculosis Treatment: A Retrospective Cohort Study
Hong Zhao et al.
MEDICAL SCIENCE MONITOR (2020)
Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
Theo Vos et al.
LANCET (2020)
Cost-effectiveness of newer technologies for the diagnosis of Mycobacterium tuberculosis infection in Brazilian people living with HIV
Ricardo E. Steffen et al.
SCIENTIFIC REPORTS (2020)
A systematic review of adverse events of rifapentine and isoniazid compared to other treatments for latent tuberculosis infection
Christopher Pease et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2018)
Short-course regimens of rifapentine plus isoniazid to treat latent tuberculosis infection in older Chinese patients: a randomised controlled study
Lei Gao et al.
EUROPEAN RESPIRATORY JOURNAL (2018)
Incidence of active tuberculosis in individuals with latent tuberculosis infection in rural China: follow-up results of a population-based, multicentre, prospective cohort study
Lei Gao et al.
LANCET INFECTIOUS DISEASES (2017)
Recurrent tuberculosis in an urban area in China: Relapse or exogenous reinfection?
Xin Shen et al.
TUBERCULOSIS (2017)
Treatment outcomes of patients with multidrug-resistant and extensively drug resistant tuberculosis in Hunan Province, China
Kefyalew Addis Alene et al.
BMC INFECTIOUS DISEASES (2017)
Annual risk of tuberculosis infection in rural China: a population-based prospective study
Lei Gao et al.
EUROPEAN RESPIRATORY JOURNAL (2016)
Benefit of treatment of latent tuberculosis infection in individual patients
Claudia C. Dobler et al.
EUROPEAN RESPIRATORY JOURNAL (2016)
Prevalence, risk factors, management, and treatment outcomes of first-line antituberculous drug-induced liver injury: a prospective cohort study
Qin Sun et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2016)
Latent tuberculosis infection in rural China: baseline results of a population-based, multicentre, prospective cohort study
Lei Gao et al.
LANCET INFECTIOUS DISEASES (2015)
Gamma Interferon Release Assays for Detection of Mycobacterium tuberculosis Infection
Madhukar Pai et al.
CLINICAL MICROBIOLOGY REVIEWS (2014)